During the past decade, PanAmerican Clinical Research conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PanAmerican Clinical Research" #1 sponsor was "ModernaTX, Inc." with 2 trials, followed by "Ascelia Pharma AB" with 1 trials sponsored, "BeiGene" with 1 trials sponsored, "KBio Inc" with 1 trials sponsored and "Meissa Vaccines, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PanAmerican Clinical Research" #1 collaborator was "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "Coalition for Epidemic Preparedness Innovations" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "PanAmerican Clinical Research" are "Covid19" (3 trials), "COVID-19" (1 trials), "COVID-19 Vaccines" (1 trials), "Cytokine Release Syndrome" (1 trials) and "Known or Suspected Focal Liver Lesions and Severe Renal Impairment" (1 trials). Many other conditions were trialed in "PanAmerican Clinical Research" in a lesser frequency.

Most popular intervention types in "PanAmerican Clinical Research" are "Biological" (5 trials), "Drug" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Active Comparator" (1 trials), "BGB-DXP593" (1 trials), "BNT162b2 vaccine" (1 trials) and "Biological/Vaccine: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)" (1 trials). Other intervention names were less common.

The vast majority of trials in "PanAmerican Clinical Research" are 9 trials for "All" genders.

Currently, there are NaN active trials in "PanAmerican Clinical Research". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in PanAmerican Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in PanAmerican Clinical Research, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".